Mestag is an immunology company driving first-in-class treatments for cancer and inflammatory diseases
Mestag is an immunology company driving first-in-class treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are rapidly advancing a pipeline of sophisticated agonist antibody programs and exploring our RAFT target discovery platform to identify new targets for the development of new treatments.